Quince Therapeutics Competitors and Similar CompaniesClear all

Quince Therapeutics's competitors and similar companies include Alector and Vertex Pharmaceuticals.

	Quince Therapeutics Quince Therapeutics (formerly known as Cortexyme) is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders.	Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.
Founding Date	Founding Date 2012	Founding Date 2013	Founding Date 1989
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development mental health pharma	Tags Healthcare biotech drug development pharma
Locations	Locations San Francisco, US HQ	Locations San Francisco, US HQ	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more
Employees	Employees 2321% increase	Employees 2382% decrease	Employees 5,40013% increase
Valuation ($)	Valuation ($) 51.1 m	Valuation ($) 495.3 m	Valuation ($) 121.4 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $21m (FY, 2025)	Revenue (est.) $12b (FY, 2025)
Net income	Net income ($84m) (FY, 2025)	Net income ($142.9m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 100m	Total funding raised $ 194.5m	Total funding raised $ 2.4m